Clinical Trials
19 trialsNCT07627191 2026-06-05
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
University of Arizona
Phase EARLY_PHASE1 Not yet recruiting
NCT06937567 2026-05-26
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT07597759 2026-05-19
Phase IIT Trial of SNA009
SmartNuclide Biopharma
Phase EARLY_PHASE1 Completed
NCT05056896 2026-05-15
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Massachusetts General Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT07590856 2026-05-15
A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33
SmartNuclide Biopharma
Phase EARLY_PHASE1 Not yet recruiting
NCT07128355 2026-05-13
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Massachusetts General Hospital
Phase EARLY_PHASE1 Recruiting
NCT06653010 2026-05-07
Wondercel-UWD1
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06675513 2026-05-07
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06434376 2026-04-28
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Second Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT06034197 2026-04-08
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
Stanford University
Phase EARLY_PHASE1 Terminated
NCT03164486 2026-02-27
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
University of California, Davis
Phase EARLY_PHASE1 Active not recruiting
NCT07318389 2026-02-27
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT06475664 2026-02-12
Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial
University of Minnesota
Phase EARLY_PHASE1 Completed
NCT07343791 2026-01-15
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting
NCT07328087 2026-01-09
COLONYVAQâ„¢-CRC
Biogenea Pharmaceuticals Ltd.
Phase EARLY_PHASE1 Recruiting
NCT02304978 2025-12-26
TF
University Hospital, Lille
Phase EARLY_PHASE1 Completed
NCT07167446 2025-10-22
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07166263 2025-09-10
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07050394 2025-07-03
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Recruiting